ReaGenics is pioneering a novel plant cell bioreactor process for the mass-scale multiplication of cannabinoids. This eliminates the need to grow plants on an industrial scale for pharma-grade, botanically- derived cannabinoids.
Leveraging success with patented technology for multiplication and manipulation of lavender cells, ReaGenics is applying the same technology to cannabis, allowing for consistent, controllable, and patentable formulations.